To Determine the Safety of Regorafenib, Hydroxychloroquine, and Entinostat Metastatic Colorectal Cancer
Abramson Cancer Center at Penn Medicine
Abramson Cancer Center at Penn Medicine
Syndax Pharmaceuticals
Syndax Pharmaceuticals
Abramson Cancer Center at Penn Medicine
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)